Sponsor · clinical trials

MicroPort Orthopedics clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA, Canada, UK, Germany, Belgium, Spain, Italy and Poland registers with MicroPort Orthopedics as lead sponsor. Synced 11 Nov 2026

15Current trials

1Recruiting now

0Drugs in these trials

8Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 11 Nov 2026 · Editorial standards

At a glance

MicroPort Orthopedics is the lead sponsor of 15 current clinical trials in our USA, Canada, UK, Germany, Belgium, Spain, Italy and Poland registers. 1 is recruiting patients now. All registered phases are Observational. The most-studied condition is Joint Disease.

ClinicalTrials.gov trials by status

Recruiting17%
Active, closed960%
By invitation533%

Trials by phase

Observational15100%

Clinical trials sponsored by MicroPort Orthopedics

15 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol NCT06142669 · ClinicalTrials.gov ↗ · Joint Diseases	Observational	Recruiting	2023-10	Italy
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert NCT04816773 · Joint Diseases, Osteoarthritis, Arthritis Knee	Observational	By invitation	2022-01	UK, USA
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Z Revision Femoral Stems NCT04064008 · ClinicalTrials.gov ↗ · Joint Disease	Observational	By invitation	2019-04	Poland
Post Market Clinical Follow-Up Study Protocol for PROCOTYL® C Acetabular Components NCT03576573 · ClinicalTrials.gov ↗ · Joint Disease	Observational	By invitation	2019-03	Germany
Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK NCT04145401 · Knee Osteoarthritis	Observational	By invitation	2020-09	USA
Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem NCT04147559 · Joint Diseases	Observational	By invitation	2020-10	USA
Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts NCT02351414 · Joint Disease	Observational	Active, closed	2015-06	UK, USA, Germany, Belgium, Canada
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert NCT07391592 · Osteoarthitis, Arthritis Knee, Joint Diseases	Observational	Active, closed	2025-08	USA
Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur NCT04301622 · Knee Osteoarthritis, Traumatic Arthritis of Knee, Avascular Necrosis	Observational	Active, closed	2020-02	USA
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems NCT02239783 · ClinicalTrials.gov ↗ · Joint Disease	Observational	Active, closed	2014-11	Canada
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems NCT02314702 · Joint Disease	Observational	Active, closed	2015-09	UK
Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components NCT02285842 · ClinicalTrials.gov ↗ · Joint Disease	Observational	Active, closed	2014-12	Canada
PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components NCT02823834 · ClinicalTrials.gov ↗ · Joint Disease	Observational	Active, closed	2017-06	Germany
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Preserve Femoral Stem NCT03865667 · ClinicalTrials.gov ↗ · Joint Disease	Observational	Active, closed	2019-01	Spain
Post Market Clinical Follow-up Study Protocol for DYNASTY® BioFoam® Acetabular Components NCT02149667 · ClinicalTrials.gov ↗ · Joint Disease	Observational	Active, closed	2014-12	Canada

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Conditions in MicroPort Orthopedics trials

9 conditions

Joint Disease9Joint Diseases4Avascular Necrosis3Arthritis Knee2Knee Osteoarthritis2 Osteoarthritis1Osteoarthitis1Traumatic Arthritis of Knee1Degenerative Joint Disease of Knee1

By trial register

Register	Trials	Recruiting
Clinical trials in USA	6	0
Clinical trials in Canada	4	0
Clinical trials in UK	3	0
Clinical trials in Germany	3	0
Clinical trials in Belgium	1	0
Clinical trials in Spain	1	0
Clinical trials in Italy	1	1
Clinical trials in Poland	1	0

A trial with sites in more than one country appears in each of those registers.

Questions about MicroPort Orthopedics trials

How many clinical trials does MicroPort Orthopedics sponsor?

MicroPort Orthopedics is the lead sponsor of 15 current trials on ClinicalTrials.gov in our USA, Canada, UK, Germany, Belgium, Spain, Italy and Poland registers, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.

Are MicroPort Orthopedics trials recruiting?

Yes. 1 of its 15 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.